. Sepsis-/-septicémie,

, Institut Pasteur, 2015.

K. Reinhart, M. Bauer, N. C. Riedemann, and C. S. Hartog, New Approaches to Sepsis: Molecular Diagnostics and Biomarkers, Clinical Microbiology Reviews, vol.25, issue.4, pp.609-643, 2012.

J. D. Faix, Biomarkers of sepsis, Crit Rev Clin Lab Sci. janv, vol.50, issue.1, pp.23-36, 2013.

N. S. Ward, B. Casserly, and A. Ayala, The Compensatory Anti-inflammatory Response syndrome (CARS) in Critically ill patients, Clin Chest Med. déc, vol.29, issue.4, p.617, 2008.

R. C. Bone, R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein et al., Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, The ACCP/SCCM Consensus Conference Committee, vol.101, pp.1644-55, 1992.

M. M. Levy, M. P. Fink, J. C. Marshall, A. E. Angus, D. Cook et al., , 2001.

, SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference, vol.31, pp.1250-1256, 2003.

R. P. Dellinger, M. M. Levy, A. Rhodes, D. Annane, H. Gerlach et al., Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, Critical Care Medicine. févr, vol.41, issue.2, pp.580-637, 2013.

M. Singer, C. S. Deutschman, C. W. Seymour, M. Shankar-hari, D. Annane et al., The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), JAMA. 23 févr, vol.315, issue.8, p.801, 2016.

S. Q. Simpson, SIRS in the Time of Sepsis-3, Chest. janv, vol.153, issue.1, pp.34-42, 2018.

M. Sartelli, Y. Kluger, L. Ansaloni, T. C. Hardcastle, J. Rello et al., Raising concerns about the Sepsis-3 definitions, World J Emerg Surg, vol.25, 2018.

J. K. Aronson, Biomarkers and surrogate endpoints, Br J Clin Pharmacol. mai, vol.59, issue.5, pp.491-495, 2005.

B. Castan and F. Roblot, Biomarqueurs en pathologie infectieuse. 13emes journées d'infectiologie, 13-15 juin 2012. Tours,98p. Disponible sur, 2012.

G. Debaty, ;. La-protéine-c-réactive, Y. Claessens, P. Ray, and . Éditeurs, Les biomarqueurs en médecine d'urgence, pp.63-72, 2012.

H. Ablij and A. Meinders, C-reactive protein: history and revival, Eur J Intern Med, vol.13, issue.7, p.412, 2002.

W. Ansar and S. Ghosh, C-reactive protein and the biology of disease, Immunol Res. mai, vol.56, issue.1, pp.131-173, 2013.

P. Hausfater, . Procalcitonine, and . Crp, quelle utilisation rationnelle en médecine d'urgence de deux biomarqueurs de l'inflammation et de l'infection ?, 2009.

P. Codine, E. Barbotte, F. Denis-laroque, H. Lansac, T. Dupetit et al., Surveillance biologique après chirurgie orthopédique. Quel apport au diagnostic des complications infectieuses et thromboemboliques ? Annales de Réadaptation et de Médecine Physique, vol.48, pp.590-597, 2005.

S. Bauer and O. Lamy,

, Rev Med Suisse, vol.6, issue.269, pp.2072-2075, 2010.

J. Djuma, P. Kalenga, C. Kazadi, D. Orbegozo, and J. L. Vincent, Appréciation de la sévérité de l'affection des patients admis en réanimation par la mesure de la CRP, Pan Afr Med J, vol.20

, Pyélonéphrite aiguë de la femme

H. Autorité-de-santé,

D. Sur,

, Prise en charge des infections des voies respiratoires basses de l'adulte immunocomptent. Médecine et Maladies Infectieuses, vol.36, pp.235-279, 2006.

G. Habib, P. Lancellotti, M. J. Antunes, M. G. Bongiorni, J. Casalta et al., ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM), Eur Heart J, vol.36, issue.44, pp.3075-128, 2015.

, Spondylodiscites infectieuses primitives, et secondaire un à geste intra-discal, sans mise en place de matériel. /data/revues, 2007.

D. Sur,

, Prothèse de hanche ou de genou : diagnostic et prise en charge de l'infection dans le mois suivant l'implantation

H. Autorité-de-santé,

D. Sur,

, Appendicectomie : Eléments décisionnels pour une indication pertinente -Rapport d'évaluation

H. Autorité-de-santé,

, CC-meningites-2018_diaporama.pdf [Internet

, Prise en charge des infections cutanées bactériennes courantes -Février, JMV-Journal de Médecine Vasculaire. juin, vol.44, issue.4, pp.274-84, 2019.

M. Bernard and P. Hausfater, In: Claessens Y-É, Ray P, éditeurs. Les biomarqueurs en médecine d'urgence: Des données biologiques au lit du malade

. Paris, Références en médecine d'urgence. Collection de la SFMU), Disponible sur, pp.71-78, 2012.

M. Prucha, G. Bellingan, and R. Zazula, Sepsis biomarkers, Clin Chim Acta. 2 févr, vol.440, pp.97-103, 2015.

P. Hausfater, G. Juillien, B. Madonna-py, J. Haroche, M. Bernard et al., Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department, Crit Care, vol.11, issue.3, p.60, 2007.

N. Bele, La PCT pour diagnostiquer le sepsis en réanimation, focus sur le patient immunodéprimé, Réanimation. juin, vol.17, issue.3, pp.5-8, 2008.

D. Liu, L. Su, G. Han, P. Yan, and L. Xie, Prognostic Value of Procalcitonin in Adult Patients with Sepsis: A Systematic Review and Meta-Analysis, Disponible sur, vol.10

L. Magrini, F. Travaglino, R. Marino, E. Ferri, B. D. Berardinis et al., Procalcitonin variations after Emergency Department admission are highly predictive of hospital mortality in patients with acute infectious diseases, p.10

M. Christ-crain, D. Jaccard-stolz, R. Bingisser, M. M. Gencay, P. R. Huber et al., Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial, Lancet. 21 févr, vol.363, issue.9409, pp.600-607, 2004.

M. Christ-crain, D. Stolz, R. Bingisser, C. Müller, D. Miedinger et al., Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial, Am J Respir Crit Care Med. 1 juill, vol.174, issue.1, pp.84-93, 2006.

L. Bouadma, C. Luyt, F. Tubach, C. Cracco, A. Alvarez et al., Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial, Lancet. 6 févr, vol.375, issue.9713, pp.463-74, 2010.

H. Tang, T. Huang, J. Jing, H. Shen, and W. Cui, Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis, Infection. déc, vol.37, issue.6, pp.497-507, 2009.

P. Schuetz, M. Briel, M. Christ-crain, D. Stolz, L. Bouadma et al., Procalcitonin to Guide Initiation and Duration of Antibiotic Treatment in Acute Respiratory Infections: An Individual Patient Data Meta-Analysis, Clin Infect Dis. 1 sept, vol.55, issue.5, pp.651-62, 2012.

A. Rhodes, L. E. Evans, W. Alhazzani, M. M. Levy, M. Antonelli et al., Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock, Intensive Care Med. mars, vol.43, issue.3, pp.304-77, 2016.

X. Lu, X. , Y. Zhu, and Y. , Diagnostic value of serum procalcitonin in patients with chronic renal insufficiency: a systematic review and meta-analysis, Nephrol Dial Transplant. janv, vol.28, issue.1, pp.122-131, 2013.

L. Simon, F. Gauvin, D. K. Amre, P. Saint-louis, and J. Lacroix, Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis, Clin Infect Dis. 15 juill, vol.39, issue.2, pp.206-223, 2004.

J. Wu, S. Lee, C. Shen, Y. Hsieh, P. Yo et al., Use of serum procalcitonin to detect bacterial infection in patients with autoimmune diseases: A systematic review and metaanalysis, Arthritis & Rheumatism, vol.64, issue.9, pp.3034-3076, 2012.

L. Hu, Q. Shi, M. Shi, R. Liu, and C. Wang, Diagnostic Value of PCT and CRP for Detecting Serious Bacterial Infections in Patients With Fever of Unknown Origin: A Systematic Review and Metaanalysis, Appl Immunohistochem Mol Morphol, vol.25, issue.8, pp.61-70, 2017.

C. Shen, M. Wu, K. Lin, W. Lin, H. Chen et al., The use of procalcitonin in the diagnosis of bone and joint infection: a systemic review and meta-analysis, Eur J Clin Microbiol Infect Dis. juin, vol.32, issue.6, pp.807-821, 2013.

G. G. Song, S. Bae, and Y. H. Lee, Diagnostic accuracies of procalcitonin and C-reactive protein for bacterial infection in patients with systemic rheumatic diseases: a meta-analysis, Clin Exp Rheumatol. avr, vol.33, issue.2, pp.166-73, 2015.

M. Tan, Y. Lu, H. Jiang, and L. Zhang, The diagnostic accuracy of procalcitonin and C-reactive protein for sepsis: A systematic review and meta-analysis, J Cell Biochem. avr, vol.120, issue.4, pp.5852-5861, 2019.

C. Wu, J. Wu, C. Chen, S. Huang, S. Hsu et al., Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis. Support Care Cancer, vol.23, pp.2863-72, 2015.

C. Yu, J. Wu, M. Shen, C. Wu, J. Lee et al., Systematic review and meta-analysis of the diagnostic accuracy of procalcitonin, C-reactive protein and white blood cell count for suspected acute appendicitis, Br J Surg. févr, vol.100, issue.3, pp.322-331, 2013.

J. Zhao, S. Zhang, L. Zhang, X. Dong, J. Li et al., Serum procalcitonin levels as a diagnostic marker for septic arthritis: A meta-analysis, Am J Emerg Med. août, vol.35, issue.8, pp.1166-71, 2017.

C. Yu, J. Hsu, S. Chen, C. Wu, C. Lee et al., Role of procalcitonin in the diagnosis of infective endocarditis: a meta-analysis, Am J Emerg Med. juin, vol.31, issue.6, pp.935-976, 2013.

, Concordance de deux variables : les approches numériques -EM|consulte

J. Bittan, La CRP est-elle corrélée avec les décisions d'hospitalisation dans une structure d'urgences adultes ?, 2006.

N. Asseray, C. Leconte, E. Kouri, D. Touzé, M. D. Struillou et al.,

, Presse Med. 23 avr, vol.34, issue.8, pp.561-566, 2005.

. Netgen, Vieux et nouveaux biomarqueurs inflammatoires : quelle utilité pour l'interniste généraliste ?

. Revue-médicale-suisse, Disponible sur

P. Roger, H. S. Salvador-f-de, A. , A. Farhad, R. Pulcini et al., Utilité de la Creactive protein dans le suivi thérapeutique des patients infectés. /data/revues/0399077X/v39i5/S0399077X09000651, 2009.

D. Sur,

M. L. Cox, A. G. Rudd, R. Gallimore, H. M. Hodkinson, and M. B. Pepys, Real-time measurement of serum Creactive protein in the management of infection in the elderly, Age Ageing. sept, vol.15, issue.5, pp.257-66, 1986.

M. S. Moreno, H. Nietmann, C. M. Matias, and S. M. Lobo, C-reactive protein: a tool in the follow-up of nosocomial pneumonia, J Infect. sept, vol.61, issue.3, pp.205-216, 2010.

B. Durna?, M. W?tek, T. Wollny, K. Niemirowicz, M. Marzec et al., Utility of blood procalcitonin concentration in the management of cancer patients with infections, Onco Targets Ther, vol.9, pp.469-75, 2016.

M. D. De-kruif, L. C. Lemaire, I. A. Giebelen, J. Struck, N. G. Morgenthaler et al., The influence of corticosteroids on the release of novel biomarkers in human endotoxemia, Intensive Care Med. mars, vol.34, issue.3, pp.518-540, 2008.

K. Tamaki, Y. Kogata, D. Sugiyama, T. Nakazawa, S. Hatachi et al., Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases, J Rheumatol. janv, vol.35, issue.1, pp.114-123, 2008.